A detailed history of Cmt Capital Markets Trading Gmb H transactions in Moderna, Inc. stock. As of the latest transaction made, Cmt Capital Markets Trading Gmb H holds 15,165 shares of MRNA stock, worth $997,098. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,165
Holding current value
$997,098
% of portfolio
0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $1.53 Million - $2.53 Million
15,165 New
15,165 $1.8 Million
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $1 Million - $1.36 Million
8,471 New
8,471 $1.03 Million
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $337,383 - $598,614
2,850 Added 53.13%
8,214 $1.48 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $633,327 - $1.04 Million
5,364 New
5,364 $634,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Cmt Capital Markets Trading Gmb H Portfolio

Follow Cmt Capital Markets Trading Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cmt Capital Markets Trading Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Cmt Capital Markets Trading Gmb H with notifications on news.